Navigation Links
Zimmer Holdings, Inc. Reports First Quarter Financial Results
Date:4/24/2008


WARSAW, Ind., April 24 /PRNewswire-FirstCall/ --

-- Net Sales of $1.06 billion represents an increase of 11% reported (6%

constant currency)

-- Worldwide Reconstructive Sales increased 12% reported (6% constant

currency)

-- Diluted EPS were $1.02 reported, an increase of 4% over the prior year

period, and $1.04 adjusted, an increase of 6% over the prior year

period

-- Updates 2008 full year sales guidance and reaffirms earnings

-- Announces $1.25 billion stock repurchase program

Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) today reported financial results for the quarter ended March 31, 2008. The Company reported first quarter net sales of $1.06 billion, an increase of 11% reported and 6% constant currency over the first quarter of 2007. Diluted earnings per share for the quarter were $1.02 reported, an increase of 4%, and $1.04 adjusted, an increase of 6% over the prior year period.

"We are pleased with our earnings performance and cash flow generation in the first quarter," said David Dvorak, Zimmer President and CEO. "Sales results reflect continued growth in our reconstructive business and we expect to achieve higher levels of penetration with new products as the year progresses. For instance, we are well positioned to move forward with our new knee offerings that are coming on line, including the Zimmer(R) NexGen(R) LPS-Flex Mobile Knee, the Gender Solutions(TM) Natural-Knee(R) Flex and the Gender Solutions(TM) Patello-femoral Joint System. In addition, our Kinectiv(TM) Technology for hip replacement, as well as our Fitmore(TM) Hip stem, which received FDA clearance for marketing in early March, are creative and innovative additions to our portfo
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
3. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
4. Zimmer Holdings to Present at Upcoming Investor Conferences
5. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
6. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
7. Zimmer Holdings to Present at JPMorgan Healthcare Conference
8. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
9. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
10. Zimmer Reports Fourth Quarter and 2007 Financial Results
11. Zimmer Holdings to Present at Merrill Lynch Health Care Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...mptoms, study finds , , WEDNESDAY, Nov....are among the potential problems faced by long-ter...with cisplatin-based chemotherapy, a new study has...n treated for unilateral testicular cancer between... conducted from 1998 to 2002. , The researchers...
(Date:11/25/2009)...Newswire/--TheAmericanAssociationforHomecareendors...hichisdesignedtosubstantiallyimprovetoolsandresour...roducedbySen.GeorgeLeMieux(R-Fla.). ,, TheLeMie...ionforHomecareoutlinedinits13-pointanti-fraudactio...ary.Thoseprovisionsincludecallingforreal-timeaudit...
(Date:11/25/2009)...lso can reverse a rare stomach disorder and should... researchers at Vanderbilt University Medical Cent...hickening of the stomach lining, severe abdominal ...welling in the feet and ankles due to protein loss...r. Previously, the only effective treatment was ga...
(Date:11/25/2009)...icked parts of speech colored perception of sounds... -- People can "hear" not only with their ears, bu...n fact, sensations on the skin designed to mimic c...pher sounds better, the Canadian scientists found....could use tactile information in this way," said B...
(Date:11/25/2009)...e premier resource for life science careers and in...rest™ Hotbed Campaign this morning. , ...25, 2009 -- BioSpace.com, the premier resource for...e third edition of the BioForest™ Hotbed Cam...n is a promotional effort highlighting biotechnolo...
Breaking Medicine News(10 mins):Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...ico City- Mexico's Defense Services will be bound ... re-instate HIV-infected// soldiers who were fired...e Supreme Court enforced that the armed forces can... Senior officials in the army and navy have gone ...
... York, 'American Idol' judge Simon Cowell has no s...s singers' recent breakdowns// and stints in rehab....com quoted him as saying: 'It's very fashionable ...r themselves. I don't know what's going on in Spea...
...Woman was taken out of man; Not out of his hea...ed underfoot//; But out of his side to be equa...ar his heart to be loved” ???? - Anonymous ... reach their crescendo on the 8th, the Internatio...
...anence of anthrax spores in Smailholm and the bord...stigating a decontamination operation// at a villa...d. NHS Borders have deputed the New York-bas...the Borders, including Smailholm Village Hall. ...
...edical college counsellor set afire by his patient...h Chandra Bose Medical College hospital// in Jabal...ednesday. The counsellor, Sanjay Shrivastava...ines for treating AIDS. The patient was unde...
...thquake in Tehran,Iran, has injured at least 35 pe... were destroyed when a moderate// quake measuring... Wednesday. The epicentre of the quake, whic...and a stampede due to widespread panic caused the ...
Other Medicine News:Health News:Diminishing Differences and Empowering Eves 2Health News:Diminishing Differences and Empowering Eves 3
(Date:11/25/2009)...wire/--CempraPharmaceuticalsInc.todayannouncedthat...icer,willpresentatthePiperJaffray21stAnnualHealthC...YorkPalaceHotelinNewYorkCity.Dr.Fernandeswillprovi...icalprogramsforthetreatmentofdrug-resistantpathoge... ,, Foundedin2006,CempraPharmaceuticalsisapriv...
(Date:11/25/2009)...ESBURG,November25/PRNewswire/--,iThembaPharmaceuti...y,thattheyhavesignedacollaborativeagreementtojoint...ldclasscomputationalchemistryandleaddiscoveryexper...ovidemedicinaland,syntheticchemistrysupporttoproje...ork.iThembaPharmaceuticalsandPyxisDiscovery,alsoan...
(Date:11/24/2009)...e-Asia/--ChindexInternational,Inc.,("Chindex")(Nas...estern,healthcareproductsandservicesinthePeople,sR...tendthe21stAnnualPiperJaffray,"Unplugged"HealthCar...PalaceHotel. , Managementiscurrentlyscheduled...oldone-on-onemeetingsthroughouttheday.Awebcast,oft...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Chindex International to Present at Piper Jaffray Health Care Conference 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 1WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 3WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 4Senesco Presents Pre Clinical Stability and Biological Activity Data on SNS 01 at the 2009 AACR NCI EORTC Molecular Targets and Cancer Therapeutics Co 6207 1Senesco Presents Pre Clinical Stability and Biological Activity Data on SNS 01 at the 2009 AACR NCI EORTC Molecular Targets and Cancer Therapeutics Co 6207 2Senesco Presents Pre Clinical Stability and Biological Activity Data on SNS 01 at the 2009 AACR NCI EORTC Molecular Targets and Cancer Therapeutics Co 6207 3Thoratec Investor Meeting to Review HeartMate II 28R 29 Destination Therapy Trial Data to Be Webcast 6202 1
...ecting Communities for Drug Safety,Collaboration" ... use of,electronic health information to support p... The non-profit eHealth,Initiative (eHI) announce...Food and Drug Administration (FDA) on the Sentinel...tor program aimed at improving the,nation,s abilit...
...22 On May 21,2008 at the World Congress of Cardio...rspectives in Atrial Fibrillation Management" chai..., St George,s University of,London, highlighted th...l,trial results, on the potential management of at...hmia., "ATHENA is truly a landmark trial, that ma...
Other Medicine Technology:eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 2eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 3eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 4eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 5ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6
PocketBilling©
MD Coder Web Edition 2006
ICD Finder
ZapBill Anesthesia
Medicine Products: